Manufacturing the future of nanomedicine

European Commission – The EU-funded B-SMART project, established to treat a range of neurodegenerative conditions, has taken a significant step towards this aim by selecting a platform to manufacture its nanomedicines.

Precision NanoSystem's NanoAssemblr™ will use RNA-based therapeutics to stem disease producing proteins for conditions such as Parkinson’s, Alzheimer’s and Huntington’s. These illnesses affect over seven million people across Europe, with a socio-economic burden previously estimated at around 130 billion euros per year.

Read more at European Commission.

News Image
Image Citation

Department of Defense